{"disease":{"id":"neoplasms-brain","name":"neoplasms brain"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06001073","title":"Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT04654975","title":"Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT06118723","title":"The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)","phase":"","overall_status":"RECRUITING","enrollment_count":784,"lead_sponsor_name":"Jasper Gerritsen","has_results":false},{"nct_id":"NCT02568267","title":"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":534,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT06273176","title":"The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma","phase":"","overall_status":"RECRUITING","enrollment_count":225,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT06036732","title":"A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score","phase":"","overall_status":"UNKNOWN","enrollment_count":223,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT05062772","title":"Brain Tumor Intraoperative Ultrasound Database","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Hospital del Rio Hortega","has_results":false},{"nct_id":"NCT05538130","title":"A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT03429127","title":"Normal Saline Vrs Balanced i.v. Fluids in Neurosurgery","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Clinical Hospital Centre Zagreb","has_results":false},{"nct_id":"NCT02285439","title":"Study of MEK162 for Children With Low-Grade Gliomas","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Children's Hospital Los Angeles","has_results":true},{"nct_id":"NCT05241873","title":"(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":103,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT06128148","title":"Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":101,"lead_sponsor_name":"Guangzhou JOYO Pharma Co., Ltd","has_results":false},{"nct_id":"NCT05946928","title":"EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05850377","title":"5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Sociedad de Lucha Contra el Cáncer del Ecuador","has_results":false},{"nct_id":"NCT01677741","title":"A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT02334722","title":"1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT03028337","title":"Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04859543","title":"Pediatric Prospective Personalized Immune and Target Identification Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Masaryk University","has_results":false},{"nct_id":"NCT03434262","title":"SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT04543188","title":"A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":65,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07023640","title":"Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT00639639","title":"Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Gary Archer Ph.D.","has_results":false},{"nct_id":"NCT06770335","title":"The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Great Ormond Street Hospital for Children NHS Foundation Trust","has_results":false},{"nct_id":"NCT00626483","title":"Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Gary Archer Ph.D.","has_results":false},{"nct_id":"NCT02193347","title":"IDH1 Peptide Vaccine for Recurrent Grade II Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Katy Peters, MD, PhD","has_results":true},{"nct_id":"NCT03911388","title":"HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT02900248","title":"CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice","phase":"","overall_status":"TERMINATED","enrollment_count":23,"lead_sponsor_name":"CureOne","has_results":false},{"nct_id":"NCT03435952","title":"Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":18,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06322342","title":"Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reveal Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT03525080","title":"Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Center Eugene Marquis","has_results":false},{"nct_id":"NCT02692898","title":"Biomarker Analysis of Central Nervous System Tumors","phase":"","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04657315","title":"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"CHA University","has_results":false},{"nct_id":"NCT05131815","title":"The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT02279992","title":"Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT04644315","title":"A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT04482933","title":"HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pediatric Brain Tumor Consortium","has_results":false}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}